Impact of myocardial revascularization on neurohormonal and hemodynamic parameters in patients with acute myocardial infarction
Abstract
Background. The COVID-19 pandemic has posed significant health risks, particularly for elderly patients. Studies on the impact of COVID-19 in this age group have highlighted various atypical clinical manifestations, complications, and challenges in diagnosis and treatment. The purpose of this article is to explore the distinct features of COVID-19 in elderly individuals and propose effective diagnostic and treatment methods.
Materials and Methods. This article analyzes data from 20 clinical studies involving 4,965 elderly patients aged 60 years and older. The studies assess the clinical symptoms, laboratory findings, and complications associated with COVID-19 in older adults. Various diagnostic tools, including polymerase chain reaction (PCR) tests and imaging techniques, are discussed, along with treatment regimens used in these cases.
Results. The findings indicate that elderly patients often exhibit atypical clinical signs such as cognitive dysfunction, weakness, and unusual gastrointestinal symptoms. Laboratory results commonly show lymphocytopenia, elevated D-dimer levels, and increased C-reactive protein levels. Complications like acute kidney injury, liver dysfunction, and secondary bacterial infections are prevalent, and the need for ventilatory support is higher in this group compared to younger populations. Conclusion. Effective management of COVID-19 in elderly patients requires prompt diagnosis, tailored treatment strategies, and careful monitoring of complications. Further research is needed to develop more specific protocols for this vulnerable age group.
About the Authors
List of references
Kovalev S.A., Malikov V.E., Effectiveness of pharmacotherapy in normalizing the level of brain natriuretic peptide and activity of the renin-angiotensin-aldosterone system after myocardial revascularization in patients with post-infarction cardiosclerosis, Cardiovascular Therapy and Prevention, 2016, 15, 06, 39-45, 10.15829/1728-8800-2016-6-39-45.
Osipova O.A., Nagibina A.I., Komisov A.A., Pathomorphological mechanisms of myocardial fibrosis regulation in patients with chronic heart failure against the background of ischemic heart disease, Heart Failure, 2019, 17, 05, 357-364, https://www.rmj.ru/articles/kardiologiya/.
Revishvili A.Sh., Golitsyn S.P., Egorov D.F., Russian Clinical Guidelines for the Control of Sudden Cardiac Arrest and Sudden Cardiac Death, Prevention and First Aid, Bulletin of Arrhythmology, 2017, 89, 2-104, https://vestar.elpub.ru/jour/article/view/77.
Uskov V.M., Modeling, Algorithmization, and Forecasting of Outcomes in Transmural Myocardial Infarction with Various Medication Schemes: Author’s Abstract for Medical Sciences Dissertation, Voronezh State Technical University, , 2004, https://www.dissercat.com/content/modelirovanie- algoritmizatsiya-i-prognozirovanie-iskhodov-transmuralnogo-infarkta-miokarda.
Fomin I.V., Chronic Heart Failure in the Russian Federation: What We Know Today and What We Should Do, Russian Cardiological Journal, 2016, 8, 0136, 7-13, 10.15829/1560-4071-2016-8-7-13.
Bouisset F., Gerbaud E., Bataille V., Coste P., Puymirat E., Belle L., Percutaneous Myocardial Revascularization in Late-Presenting Patients with STEMI, Journal of the American College of Cardiology, 2021, 78, 1291-1305, 10.1016/j.jacc.2021.07.039.
Chackerian A.A., Oldham E.R., Murphy E.E., Schmitz J., Pflanz S., Kastelein R.A., IL-1 Receptor Accessory Protein and ST2 Comprise the IL-33 Receptor Complex, Journal of Immunology, 2007, 179, 04, 2551-2555, 10.4049/jimmunol.179.4.2551.
Ciccone M.M., Cortese F., Gesualdo M., Riccardi R., Di Nunzio D., Moncelli M., Iacoviello M., Scicchitano P.A., Novel Cardiac Biomarker: ST2: A Review, Molecules, 2013, 18, 15314-15328, 10.3390/molecules181215314.
Felker G.M., Fiuzat M., Thompson V., Shaw L.K., Neely M.L., Adams K.F., Whellan D.J., Donahue M.P., Ahmad T., Kitzman D.W., Pina I.L., Zannad F., Kraus W.E., O’Connor C.M., Soluble ST2 in Ambulatory Patients with Heart Failure: Association with Functional Capacity and Long-Term Outcomes, Circulation: Heart Failure, 2013, 6, 1172-1179, 10.1161/CIRCHEARTFAILURE.113.000207.
Go A.S., Mozaffarian D., Roger V.L., Heart Disease and Stroke Statistics-2014 Update: A Report from the American Heart Association, Circulation, 2014, 129, 03, 280-292, 10.1161/01.cir.0000441139.02102.80.
Gravning J., Smedsrud M.K., Omland T., Eek C., Skulstad H., Aaberge L., Bendz B., Kjekshus J., Morkrid L., Edvardsen T., Sensitive Troponin Assays and N-Terminal Pro-B-Type Natriuretic Peptide in Acute Coronary Syndrome: Prediction of Significant Coronary Lesions and Long-Term Prognosis, American Heart Journal, 2013, 165, 05, 716-724, 10.1016/j.ahj.2013.02.008.
Mosterd A., Hoes A.W., Clinical Epidemiology of Heart Failure, Heart, 2007, 93, 1137-1146, 10.1161/01.cir.0000441139.02102.80.
Maries L., Manitiu I., Diagnostic and Prognostic Values of B-Type Natriuretic Peptides (BNP) and N-terminal Fragment Brain Natriuretic Peptides (NT-pro-BNP), Cardiovascular Journal of Africa, 2013, 24, 07, 286-289, 10.5830/cvja-2013-055.
Menon V., Pearte C.A., Buller C.E., Steg Ph.G., Forman S.A., White H.D., Lack of Benefit from Percutaneous Intervention of Persistently Occluded Infarct Arteries after the Acute Phase of Myocardial Infarction is Time Independent: Insights from Occluded Artery Trial, European Heart Journal, 2009, 30, 183-191, 10.1093/eurheartj/ehn486.
Nichols M., Townsend N., Scarborough P., Rayner M., Cardiovascular Disease in Europe 2014: Epidemiological Update, European Heart Journal, 2014, 35, 042, 2950-2959, 10.1093/eurheartj/ehu299.
Scho¨mig A., Mehilli J., Antoniucci D., Ndrepepa G., Markwardt C., Di Pede F., Mechanical Reperfusion in Patients with Acute Myocardial Infarction Presenting More Than 12 Hours from Symptom Onset: A Randomized Controlled Trial, JAMA, 2005, 293, 2865-2872, 10.1001/jama.293.23.2865.
Steg P.G., Dabbous O.H., Feldman L.J., Determinants and Prognostic Impact of Heart Failure Complicating Acute Coronary Syndromes: Observations from the Global Registry of Acute Coronary Events (GRACE), Circulation, 2004, 109, 494-499, 10.1161/01.cir.0000109691.16944.da.
Ndrepepa G., Kastrati A., Mehilli J., Antoniucci D., Scho¨mig A., Mechanical Reperfusion and Long-Term Mortality in Patients with Acute Myocardial Infarction Presenting 12 to 48 Hours from Onset of Symptoms, JAMA, 2009, 301, 487-488, 10.1001/jama.2009.32.
Copyright (c) 2024 С.Ж. Муминов, Г.М. Тулабоева, Ю.Ш. Талипова, А.А. Мангосян, Н.М. Абдукадирова, Ж.И. Тоштемиров (Автор)
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.